Healthcare
Country
Transactions: Sweden
Filter
Healthcare
Rights issue in Oasmia Pharmaceutical (SE) — SEK 123 million
Real Estate
New share issue in Fastighets AB Klövern (SE) — SEK 260 million
FIG
Secondary placing of 7 million shares in Intrum Justitia (SE) — EUR 41 million
Healthcare
Rights issue in Active Biotech (SE) — SEK 255 million
Healthcare
Option program in Biovitrum (SE)
Healthcare
Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion
Healthcare
Public offer for Biacore International (SE) by GE Healthcare (US) — SEK 3.2 billion
Healthcare
Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million
Real Estate
Initial public offering of Castellum (SE) — SEK 1.8 billion
Business Services
Divestment of Infratek ASA (NO) to Triton (SE) by Hafslund ASA (NO) and Fortum Nordic AB (SE) — NOK 0.9 billion
FIG